omniture
LUNIT INC

Latest News

Lunit Partners with CARPL.ai to Accelerate AI-Powered Medical Imaging Across Major Overseas Channels

* Lunit signed a global distribution agreement to provide its AI-based radiology solutions for cl...

2022-11-23 12:30 3464

Lunit Becomes the First Medical Software Company in Asia-Pacific to Become MDR CE and UKCA Certified

* Lunit becomes first software as a medical device (SaMD) company in APAC to become MDR CE and UK...

2022-11-21 21:00 2633

Lunit to Supply AI Platform to Australia's BreastScreen NSW Machine Reading Project

* Lunit's INSIGHT MMG solution has been selected for mammogram screening in Australia's BreastScr...

2022-11-16 21:11 3553

Lunit Highlights the Effectiveness of AI in Acceleration of Immunotherapy Research--Findings to be Presented at SITC 2022

* Lunit to present three abstracts featuring Lunit SCOPE IO, the company's AI biomarker for immun...

2022-11-07 21:00 1969

Real-World Application of Lunit INSIGHT to be Spotlighted at RSNA 2022 (Oral Presentations)

* 7 oral presentations and 1 e-poster highlighting Lunit's most up-to-date research on its AI sol...

2022-11-01 22:00 2313

Lunit Joins World Economic Forum Global Innovators Community

* Lunit invited to join the World Economic Forum's Global Innovators Community, an invitation-onl...

2022-10-26 21:00 2544

Lunit Showcases AI Solutions for Radiology at AOCR & KCR 2022

* Lunit participates in the 20th Asian Oceanian Congress of Radiology and 78th Annual Meeting of ...

2022-09-21 22:48 1557

New Study by Lunit and MGH Validates Effectiveness of AI as Aid in Chest X-Ray Interpretation - Published in JAMA Network Open

* Joint study with Massachusetts General Hospital proves that Lunit's AI-powered chest x-ray anal...

2022-09-13 22:16 1355

Lunit Introduces AI for TB Screening to Indonesia Ministry of Health Officials

* Lunit participated in the "Indonesia AI Healthcare Course," organized by South Korean Ministry ...

2022-09-07 21:00 3255

Lunit to Showcase 5 Abstracts at ESMO 2022

* Lunit to present five posters at ESMO 2022 featuring the company's AI-biomarker platform * St...

2022-09-05 21:00 2661

Lunit AI Solution for Breast Cancer Detection Wins Commercial Approval in Taiwan

* Lunit's AI solution for mammography received a class 2 medical device license from the Taiwan F...

2022-08-25 23:13 3753

Lunit Announces Financial Results for the First Half of 2022

* Consolidated revenue in the second quarter of 2022 increased by 190% compared to same prior-yea...

2022-08-12 21:00 11894

New Immunotherapy Combination Study for Nasopharyngeal Cancer Demonstrates Effectiveness of Lunit AI as Predictive Aid in Treatment Outcome--Published in Clinical Cancer Research

* Recent clinical trial on combination immunotherapy for nasopharyngeal cancer provides evidence ...

2022-08-01 21:00 1851

AI-based Cancer Solution Pioneer Lunit Makes Market Debut

SEOUL, South Korea, July 21, 2022 /PRNewswire/ -- Lunit, a global provider of AI-powered cancer sol...

2022-07-21 21:00 1641

Lunit to be Listed on KOSDAQ next week

* Initial Public Offering of 1,215,800 shares of its common stock at KRW 30,000 * To be listed ...

2022-07-14 21:00 2047

Cathay Life Insurance to Incorporate Lunit AI Solution for Chest X-Ray into Underwriting Workflow

* Lunit and Cathay Life Insurance signed a license agreement to officially adopt Lunit's AI solut...

2022-07-06 21:00 2736

Bumrungrad International Hospital, Southeast Asia's Largest Hospital to Deploy Lunit's AI Cancer Screening System

* Lunit and FujiFilm Thailand to supply Lunit INSIGHT CXR and Lunit INSIGHT MMG to one of SEA's l...

2022-07-04 21:00 3482

Lunit Files Registration Statement for Initial Public Offering

* First Korean healthcare company to obtain "AA-AA" ratings in technology assessment for its FDA-...

2022-06-16 21:00 2520

New Studies at ASCO 2022 Validate Effectiveness of Lunit AI as Diagnostic Aid in Cancer Treatment

* Lunit to showcase 7 poster presentations and 4 online publications, the company's largest publi...

2022-05-27 08:30 2350

Lunit AI Biomarker PD-L1 Demonstrates Clinical Efficacy as Diagnostic Aid in Cancer Treatment-Published in the European Journal of Cancer

* Study findings show that Lunit's AI-powered PD-L1 TPS analyzer minimizes interpretation discrep...

2022-05-19 21:00 1294